Overview

Antiretroviral Therapy Intensification With Raltegravir or Addition of Hyper-immune Bovine Colostrum in HIV-1 Infected Patients With Suboptimal CD4+ T Cell Response

Status:
Completed

Trial end date:
2011-06-01

Target enrollment:

Participant gender:

Summary

A research study to measure the effect on CD4 counts of adding to current anti-retroviral regimen raltegravir with or without hyper-immune bovine colostrum.

Phase:

Phase 4

Details

Lead Sponsor:

Kirby Institute

Treatments:

Raltegravir Potassium